Table 1.xls (5.5 kB)
Intratumoural injection with iNSA/E6E7equ and iNSB/E6E7equ is well tolerated.
dataset
posted on 2021-11-19, 18:32 authored by Christoph Jindra, Edmund K. Hainisch, Andrea Rümmele, Markus Wolschek, Thomas Muster, Sabine BrandtIntratumoural injection with iNSA/E6E7equ and iNSB/E6E7equ is well tolerated.
History
Usage metrics
Categories
Keywords
unsuccessful therapeutic attemptstumour burden eventruncated ns1 genetransient side effectsystemic antitumour responseplaque assay revealedmay 2021 ).former tumour sitesassuring interferon inductionaffected individuals duesarcoids seriously compromiseb virus vectorsequ supdiv >< pcomplete tumour regressionvirus sheddingmultiple sarcoidswell toleratedvaccination schemessynchronous regressionstill ongoingsignificantly reducingsevere formscrapings collectedsarcoid immunotherapyrepeated screeningproved safemild feverintradermal administrationinduced singlee7 antigensdeveloped influenza
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC